Literature DB >> 25926588

Successful treatment of ulcerative bronchiolitis in a woman with refractory Mycobacterium intracellulare infection.

John Patrick Egan1, Benjamin J Seides2, Kenneth N Olivier3, Doreen Addrizzo-Harris1.   

Abstract

We present a case of a woman with medically refractory ulcerative colitis (UC) who developed severe bronchiectasis, bronchitis, bronchiolitis and Mycobacterium intracellulare (MAC) infection 2 years after total colectomy. Despite being on optimal therapy for her MAC and sterilising multiple consecutive sputum cultures, she remained highly symptomatic, and this led to further investigations that revealed the presence of UC-related airways disease. Addition of immunosuppressive therapy to her antimycobacterial treatment resulted in sustained and complete clinical remission of her disease. To our knowledge, this is the only case published in the literature that describes a case of successful treatment of concomitant UC-related pulmonary disease and symptomatic MAC. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25926588      PMCID: PMC4422916          DOI: 10.1136/bcr-2015-209604

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

Review 1.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Ian Storch; David Sachar; Seymour Katz
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

Review 2.  Rare extraintestinal manifestations of inflammatory bowel disease.

Authors:  R M Hoffmann; W Kruis
Journal:  Inflamm Bowel Dis       Date:  2004-03       Impact factor: 5.325

Review 3.  Pulmonary diseases associated with inflammatory bowel diseases.

Authors:  Giovanni Casella; Vincenzo Villanacci; Camillo Di Bella; Elisabetta Antonelli; Vittorio Baldini; Gabrio Bassotti
Journal:  J Crohns Colitis       Date:  2010-03-17       Impact factor: 9.071

Review 4.  Pulmonary manifestations of inflammatory bowel disease: case presentations and review.

Authors:  Benjamin Basseri; Pedram Enayati; Alberto Marchevsky; Konstantinos A Papadakis
Journal:  J Crohns Colitis       Date:  2010-10       Impact factor: 9.071

5.  Respiratory impairment in inflammatory bowel disease: does it vary with disease activity?

Authors:  J G Douglas; C F McDonald; M J Leslie; J Gillon; G K Crompton; G J McHardy
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

6.  Clinical and radiological characteristics of lung disease in inflammatory bowel disease.

Authors:  R Mahadeva; G Walsh; C D Flower; J M Shneerson
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

7.  Constrictive bronchiolitis and ulcerative colitis.

Authors:  H Ward; K L Fisher; R Waghray; J L Wright; S E Card; D W Cockcroft
Journal:  Can Respir J       Date:  1999 Mar-Apr       Impact factor: 2.409

8.  Unexplained bronchopulmonary disease with inflammatory bowel disease.

Authors:  S C Kraft; R H Earle; M Roesler; J R Esterly
Journal:  Arch Intern Med       Date:  1976-04

9.  Large airway disease associated with inflammatory bowel disease.

Authors:  A Spira; R Grossman; M Balter
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

Review 10.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

View more
  1 in total

Review 1.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.